CN Bio and Pharmaron Partner to Advance Organ-on-a-Chip Integration in Drug R&D

CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, announced the establishment o...

April 25, 2025 | Friday | News
Optimizing Drug Launch Strategies with DelveInsight for Primary Immunodeficiency Therapies

To gain a competitive edge, the company partnered with DelveInsight to analyze competitor launch timelines, first-to-market companies, ...

March 11, 2025 | Tuesday | News
Chime Biologics Advances MG-K10, Novel IL-4Rα Antibody, into U.S. Phase III Trials with Mabgeek

Chime Biologics, a leading global CDMO that enables its partners success in biologics, announced its continued collaboration with Mabgeek in adva...

February 24, 2025 | Monday | News
Vanda Pharmaceuticals and AnaptysBio Enter Exclusive Global License Agreement for Imsidolimab in GPP Treatment

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) announced an exclusive, global license agreement ...

February 04, 2025 | Tuesday | News
GHIT Fund Announces JPY 2 Billion Investment in New Diagnostics and Drugs for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight...

January 30, 2025 | Thursday | News
Stuart Therapeutics Completes Phase III Study of ST-100 for Dry Eye Disease, Topline Data Expected in February 2025

Stuart Therapeutics, Inc. (Stuart), a clinical-stage drug platform company developing novel therapies for ophthalmic diseases,  announced last patient...

January 23, 2025 | Thursday | News
Partner Therapeutics Partners with BARDA to Fund Phase 2 Study of LEUKINE in Sepsis Patients

Partner Therapeutics, Inc. (PTx) announced a collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administrat...

January 10, 2025 | Friday | News
Veralox Therapeutics Acquires Nudge Therapeutics to Advance Preclinical cGAS Inhibitor Compounds

 Veralox Therapeutics, a clinical-stage biotechnology company developing a new class of therapies targeting the 12-lipoxygenase (12-LOX) pathway, anno...

January 10, 2025 | Friday | News
Amarna Therapeutics Forms Strategic Partnership with NorthX Biologics to Advance Gene Therapy Development

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company specializing in transformative gene therap...

December 04, 2024 | Wednesday | News
MGI Tech and Universidad de San Martín de Porres Forge Alliance to Advance Genetic Research in Peru

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, announced a partnership with...

December 02, 2024 | Monday | News
Taiwan’s Formosa Pharmaceuticals Partners with Medvisis to Launch Innovative Ophthalmic Treatment in Switzerland and Liechtenstein

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switze...

November 29, 2024 | Friday | News
Bio-Rad Advances Oncology Diagnostics with IVDR Certification for CML Assay and Strategic Collaborations in MRD and ctDNA Detection

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced updates on its onco...

November 13, 2024 | Wednesday | News
AbbVie and Gedeon Richter Forge New Agreement to Explore Treatments for Neuropsychiatric Disorders

 AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for ...

October 25, 2024 | Friday | News
Maximize Time for Innovation: Strategies for Reducing Non-Core Tasks in the Lab

  Yet, many scientists find their days consumed by non-core tasks such as reagent preparation, instrument setup, and consumables management. These ...

August 09, 2024 | Friday | Product Spotlight

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close